Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Burgess, Stephen ^a   Freitag, Daniel F ^a   Khan, Hassan ^a   Gorman, Donal N ^a   Thompson, Simon G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALLELE; ARTICLE; BLOOD PRESSURE; BODY MASS; CORONARY ARTERY DISEASE; CORONARY RISK; GENETIC VARIABILITY; HUMAN; MULTIVARIABLE MENDELIAN RANDOMIZATION; RANDOMIZATION; BLOOD; GENETICS; MENDELIAN RANDOMIZATION ANALYSIS; RISK FACTOR;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; GENETIC VARIATION; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 84907828123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108891     Document Type: Article

References (26)

1. Davey Smith G, Ebrahim S (2003) 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? International Journal of Epidemiology 32: 1-22.
2. Greenland S (2000) An introduction to instrumental variables for epidemiologists. International Journal of Epidemiology 29: 722-729.
3. Nitsch D, Molokhia M, Smeeth L, DeStavola B, Whittaker J, et al. (2006) Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. American Journal of Epidemiology 163: 397-f03.
4. AngristJD (2006) Instrumental variables methods in experimental criminological research: what, why and how. Journal of Experimental Criminology 2: 23-44.
5. Burgess S, Thompson SG (2014) Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Submitted to American Journal of Epidemiology.
6. The Global Lipids Genetics Consortium (2013) Discovery and refinement of loci associated with lipid levels. Nature Genetics 45: 1274-1283.
7. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nature Genetics 43: 333-338.
8. Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, et al. (2013) Common variants associated with plasma triglycerides and risk for coronary artery disease. Nature Genetics 45: 1345-1352.
9. Burgess S, Butterworth A, Thompson S (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genetic Epidemiology 37: 658-665.
10. Lunn D, Thomas A, Best N, Spiegelhalter D (2000) WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility. Statistics and Computing 10: 325 -337.
11. Hindorff L, MacArthur J, Mo rales J, J unkins H, Hall P, et al. (2013) A catalog of published genome-wide association studies. Technical report, European Bioinformatics Institute. Available: www.genome.gov/gwastudies. Accessed 14-March 2014.
12. Hansen L (1982) Large sample properties of generalized method of moments estimators. Econometrica: Journal of the Econometric Society 50: 1029-1054.
13. Davey Smith G (2011) Random allocation in observational data: how small but robust effects could facilitate hypothesis-free causal inference. Epidemiology 22: 460 -463.
14. Sarwar N, Sattar N (2009) Triglycerides and coronary heart disease: have recent insights yielded conclusive answers? Current Opinion in Lipidology 20: 275 -281.
15. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, et al. (2009) Major lipids, apolipoproteins, and risk of vascular disease. Journal of the American Medical Association 302: 1993 -2000.
16. Würtz P, Kangas AJ, Soininen P, Lehtimäki T, Kähönen M, et al. (2013) Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies. Journal of the American College of Cardiology 62: 1906-1908.
17. Voight B, Peloso G, Orho-Melander M, Frikke-Schmidt R, Barbalic M, et al. (2012) Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. The Lancet 380: 572-580.
18. Burgess S (2014) Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. International Journal of Epidemiology 43: 922-929.
19. Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, et al. (2014) Mendelian randomization of blood lipids for coronary heart disease. European Heart Journal [epub ahead of print].
20. .Christenfeld N, Sloan R, Carroll D, Greenland S (2004) Risk factors, confounding, and the illusion of statistical control. Psychosomatic Medicine 868-875
21. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, et al. (2007) Effects of torcetrapib in patients at high risk for coronary events. New England Journal of Medicine 357: 2109-2122.
22. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, et al. (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. New England Journal of Medicine 367: 2089-2099.
23. Burgess S, Butterworth A, Malarstig A, Thompson S (2012) Use of Mendelian randomisation to assess potential benefit of clinical intervention. British Medical Journal 345: e7325.
24. Taylor F, Ward K, Moore T, Burke M, Davey Smith G, et al. (2011) Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 1.
25. R Core Team (2014) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.R-project.org/.
26. Wolfram Alpha LLC Wolfram-Alpha. Available: http://www.wolframalpha. com. Accessed 28-June 2014.